Rowena Schwartz, PharmD, BCOP, associate professor of pharmacy at the University of Cincinnati, joins Deborah Struth, MSN, RN, ONS research associate, to discuss the rapid emergence of biosimilar products on the market and how they’ll impact the treatment of cancer. Learn more about what biosimilars are, their approval processes, and the important things to know for practice. 

Music Credit: "Fireflies and Stardust" Kevin MacLeod (incompetech.com)

Licensed under Creative Commons: By Attribution 3.0 License http://creativecommons.org/licenses/by/3.0

 

Episode Notes:

• Biosimilars Offer New Options for Treatment and New Concepts for Patient Education
• Biosimilars: Considerations for Oncology Nurses
• S. Food and Drug Administration – Biosimilars
• American Society of Clinical Oncology Statement: Biosimilars in Oncology
• Chemotherapy, Biotherapy, and Hormonal Therapy Resources